Exposure–disease response analysis of natalizumab in subjects with multiple sclerosis
Crossref DOI link: https://doi.org/10.1007/s10928-017-9514-4
Published Online: 2017-03-01
Published Print: 2017-06
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Muralidharan, Kumar Kandadi
Steiner, Deb
Amarante, Diogo
Ho, Pei-Ran
Mikol, Dan
Elkins, Jacob
Subramanyam, Meena
Nestorov, Ivan
Funding for this research was provided by:
Biogen
License valid from 2017-03-01